Gabriela Ana Horvath

Investigator, BC Children's Hospital

Neurotransmitters are chemicals synthesized inside the brain cells (neuron). Signals from the neuron travel out a thread-like extension called the axon, which connects to the next brain cell through a gap (synapse). There are the target neurons waiting for the signal.

There are many neurotransmitters in the brain. Serotonin, dopamine, acetylcholine are three of them.

Serotonin's role in the body has been associated mainly with mood, but it has major roles in temperature regulation, pain perception, sleep regulation, gut function (irritable bowel syndrome), major vessel constriction and relaxation, blood pressure control, and even neurodegenerative disorders like ALS have been associated with serotonin.

Dopamine is a neurotransmitter involved in motor function, behaviour, and cognition.

Acetylcholine functions both in the brain and peripheral neurons as a neuromodulator, it regulates gut function, sensory and autonomic nervous system, and sleep.

My major research is to define some of these neurotransmitters' involvement in disease.

Academic Affiliations

  • Clinical Associate Professor, Division of Biochemical Genetics, Department of Pediatrics, Faculty of Medicine, University of British Columbia
  • Research Theme: Brain, Behaviour & Development
  • Research Group(s): Neurodevelopmental and Neurological Disorders; Rare Diseases

Contact Information

Location

4500 Oak St, Vancouver, BC, Canada, V6H 3N1

A Novel Gain-of-Function ITPR1 Variant Associated With a Movement Disorder Characterized by Tremor and Dystonia

American Journal of Medical Genetics Part A

Emilie T. Thberge and Bo Sun and Ruiwu Wang and Arezoo Mohajeri and Clara D. M. Van Karnebeek and Cornelius F. Boerkoel and Stephanie Huynh and Gabriella Horvath and S. R. Wayne Chen and Anna Lehman

DOI: 10.1002/ajmga.70069

02 / 2026

Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency

Journal of Inherited Metabolic Disease

Mariya Sigatullina Bondarenko and Oya Kuseyri Hbschmann and Jan Kulhnek and Roser Pons and Toni S. Pearson and Kathrin Jeltsch and Ivana Badnjarevic and Tessa Wassenberg and Gabriella Horvath and Galina Stevanovic and Manju A. Kurian and Elisenda Corts-Saladelafont and Agathe Roubertie and Vincenzo Leuzzi and Mariarita Bertoldi and Mario Mastrangelo and Birgit Assmann and Angeles Garcia-Cazorla and Thomas Opladen

DOI: 10.1002/jimd.70106

11 / 2025

DIP2BCGG repeat expansion in siblings with neurodevelopmental disability and progressive movement disorder

Emilie T. Thberge and Kate Durbano and Diane Demailly and Sophie Huby and Arezoo Mohajeri and Clara van Karnebeek and Gabriella A. Horvath and Karen Usdin and Anna Lehman and Laura Cif and Phillip A. Richmond

DOI: 10.1101/2024.06.05.24308127

06 / 2024

The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency

Journal of Inherited Metabolic Disease

Natalia Alexandra Julia-Palacios and Oya Kuseyri Hbschmann and Mireia Olivella and Roser Pons and Gabriella Horvath and Thomas Lcke and Cheuk-Wing Fung and Suet-Na Wong and Elisenda Corts-Saladelafont and M. Mar Rovira-Remisa and Yilmaz Yildiz and Saadet Mercimek-Andrews and Birgit Assmann and Galina Stevanovic and Filippo Manti and Heiko Brennenstuhl and Sabine Jung-Klawitter and Kathrin Jeltsch and H. Serap Sivri and Sven F. Garbade and ngels Garca-Cazorla and Thomas Opladen

DOI: 10.1002/jimd.12723

05 / 2024

Macrocytosis in Mitochondrial DNA Deletion Syndromes

Acta Haematologica

Farida Almarzooqi and Hilary Vallance and Michelle Mezei and Anna Lehman and Gabriella Horvath and Bojana Rakic and Leslie Zypchen and Andre Mattman

DOI: 10.1159/000529311

Psychiatric Manifestations in Patients with Biopterin Defects

Neuropediatrics

Maksim Parfyonov and Robin Friedlander and Brian Banno and Dean Elbe and Gabriella Horvath

DOI: 10.1055/s-0042-1742323

06 / 2022

Recurrent Dystonic Crisis and Rhabdomyolysis Treated with Dantrolene in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency

Neuropediatrics

J. Micallef and S. Stockler-Ipsiroglu and C.D. van Karnebeek and R. Salvarinova-Zivkovic and G. Horvath

DOI: 10.1055/s-0039-3402010

06 / 2020

Correlation Between Salivary, Platelet and Central Serotonin Levels in Children

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Csilla Egri and Mary Dunbar and Gabriella Ana Horvath

DOI: 10.1017/cjn.2019.334

03 / 2020

Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells

Cells

Liza Douiev and Ruth Sheffer and Gabriella Horvath and Ann Saada

DOI: 10.3390/cells9020301

01 / 2020

Improvement of Self-Injury With Dopamine and Serotonin Replacement Therapy in a Patient With a Hemizygous PAK3 Mutation: A New Therapeutic Strategy for Neuropsychiatric Features of an Intellectual Disability Syndrome

Journal of Child Neurology

Gabriella A. Horvath and Maja Tarailo-Graovac and Tanja Bartel and Simone Race and Margot I. Van Allen and Ingrid Blydt-Hansen and Colin J. Ross and Wyeth W. Wasserman and Mary B. Connolly and Clara D. M. van Karnebeek

DOI: 10.1177/0883073817740443

01 / 2018

Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy

Journal of the Neurological Sciences

Gabriella A. Horvath and Lorelyn Meisner and Kathryn Selby and Robert Stowe and Bruce Carleton

DOI: 10.1016/j.jns.2017.04.047

07 / 2017

Debunking Occam's razor: Diagnosing multiple genetic diseases in families by whole exome sequencing.

Balci TB and Hartley T and Xi Y and Dyment DA and Beaulieu CL and Bernier FP and Dupuis L and Horvath G and Mendoza-Londono R and Prasad C and Richer J and Yang XR and Armour CM and Bareke E and Fernandez BA and McMillan HJ and Lamont R and Majewski J and Parboosingh J and Narayan Prasad A

DOI: 10.1111/cge.12987 PubMed: 28170084

02 / 2017

The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders.

Opladen T and Corts-Saladelafont E and Mastrangelo M and Horvath G and Pons R and Lopez-Laso E and Fernndez-Ramos JA and Honzik T and Pearson T and Friedman J and Scholl-Brgi S and Wassenberg T and Jung-Klawitter S and Kuseyri O and Jeltsch K and Kurian MA and Garcia-Cazorla and International Working Group on Neurotransmitter related disorders (iNTD)

DOI: 10.1016/j.ymgmr.2016.09.006 PubMed: 27830117

12 / 2016

Eye Findings on Vigabatrin and Taurine Treatment in Two Patients with Succinic Semialdehyde Dehydrogenase Deficiency.

Horvath GA and Hukin J and Stockler-Ipsiroglu SG and Aroichane M

DOI: 10.1055/s-0036-1583183 PubMed: 27104484

08 / 2016

Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?

Horvath GA and Demos M and Shyr C and Matthews A and Zhang L and Race S and Stockler-Ipsiroglu S and Van Allen MI and Mancarci O and Toker L and Pavlidis P and Ross CJ and Wasserman WW and Trump N and Heales S and Pope S and Cross JH and van Karnebeek CD

DOI: 10.1016/j.ymgme.2015.11.008 PubMed: 26647175

01 / 2016

Deep brain stimulation and dantrolene for secondary dystonia in x-linked adrenoleukodystrophy.

van Karnebeek C and Horvath G and Murphy T and Purtzki J and Bowden K and Sirrs S and Honey CR and Stockler S

DOI: 10.1007/8904_2014_305 PubMed: 24718842

Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood.

van Karnebeek CD and Sly WS and Ross CJ and Salvarinova R and Yaplito-Lee J and Santra S and Shyr C and Horvath GA and Eydoux P and Lehman AM and Bernard V and Newlove T and Ukpeh H and Chakrapani A and Preece MA and Ball S and Pitt J and Vallance HD and Coulter-Mackie M and Nguyen H

DOI: 10.1016/j.ajhg.2014.01.006 PubMed: 24530203

03 / 2014

A novel recurrent mutation in ATP1A3 causes CAPOS syndrome.

Demos MK and van Karnebeek CD and Ross CJ and Adam S and Shen Y and Zhan SH and Shyr C and Horvath G and Suri M and Fryer A and Jones SJ and Friedman JM and FORGE Canada Consortium

DOI: 10.1186/1750-1172-9-15 PubMed: 24468074

01 / 2014

Long-term outcomes of blood phenylalanine concentrations in children with classical phenylketonuria.

Hartnett C and Salvarinova-Zivkovic R and Yap-Todos E and Cheng B and Giezen A and Horvath G and Lillquist Y and Vallance H and Stockler-Ipsiroglu S

DOI: 10.1016/j.ymgme.2013.01.007 PubMed: 23465864

04 / 2013

Three years experience with dried blood spot a-glucosidase screening for Pompe disease in British Columbia, Canada.

Horvath G and Sirrs S and Stockler S and Salvarinova-Zivkovic R and Vallance H and Waters P

DOI: 10.1186/1471-2474-14-s2-p2

Profound neonatal hypoglycemia and lactic acidosis caused by pyridoxine-dependent epilepsy.

Mercimek-Mahmutoglu S and Horvath GA and Coulter-Mackie M and Nelson T and Waters PJ and Sargent M and Struys E and Jakobs C and Stockler-Ipsiroglu S and Connolly MB

DOI: 10.1542/peds.2011-0123 PubMed: 22529283

05 / 2012

The use of parenteral nutrition for the management of PKU patient undergoing chemotherapy for lymphoma: a case report.

Salvarinova-Zivkovic R and Hartnett C and Sinclair G and Dix D and Horvath G and Lillquist Y and Stockler-Ipsiroglu S

DOI: 10.1016/j.ymgme.2012.01.007 PubMed: 22305856

04 / 2012

Failure of repeated cyclophosphamide pulse therapy in childhood cerebral X-linked adrenoleukodystrophy.

Horvath GA and Eichler F and Poskitt K and Stockler-Ipsiroglu S

DOI: 10.1055/s-0032-1307455 PubMed: 22430161

02 / 2012

Hemiplegic migraine, seizures, progressive spastic paraparesis, mood disorder, and coma in siblings with low systemic serotonin.

Horvath GA and Selby K and Poskitt K and Hyland K and Waters PJ and Coulter-Mackie M and Stockler-Ipsiroglu SG

DOI: 10.1177/0333102411420584 PubMed: 22013141

11 / 2011

Treatment of intractable epilepsy in a female with SLC6A8 deficiency.

Mercimek-Mahmutoglu S and Connolly MB and Poskitt KJ and Horvath GA and Lowry N and Salomons GS and Casey B and Sinclair G and Davis C and Jakobs C and Stockler-Ipsiroglu S

DOI: 10.1016/j.ymgme.2010.08.016 PubMed: 20846889

12 / 2010

Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms.

Horvath GA and Stockler-Ipsiroglu SG and Salvarinova-Zivkovic R and Lillquist YP and Connolly M and Hyland K and Blau N and Rupar T and Waters PJ

DOI: 10.1016/j.ymgme.2008.01.003 PubMed: 18276179

05 / 2008

Newborn screening for MCAD deficiency: experience of the first three years in British Columbia, Canada.

Horvath GA and Davidson AG and Stockler-Ipsiroglu SG and Lillquist YP and Waters PJ and Olpin S and Andresen BS and Palaty J and Nelson J and Vallance H

PubMed: 18767270

Report of a fourth individual with a lethal syndrome of choanal atresia, athelia, evidence of renal tubulopathy, and family history of neck cysts.

Horvath GA and Armstrong L

DOI: 10.1002/ajmg.a.31734 PubMed: 17486625

06 / 2007

Current Projects

Metabolomics in CSF (spinal fluid) in patients with secondary neurotransmitter deficiencies. Collaborating with a metabolomics Lab in Calgary to characterize and find common abnormalities in more than 150 CSF samples from patients who were found to have CSF neurotransmitter deficiencies, but no primary genetic neurotransmitter deficiency disorder was found.

Current Projects

Calcium imaging in human neuronal Induced Pluripotential Cells (iPSC’s) derived from patients with channelopathies (SCN1A mutations). Characterization of Calcium imaging shows that these neurons are a good experimental model for seizure generation and treatment response.

Current Projects

Participating in an international project with France, on validation of clinical and deep learning-based tool for recognition and assessment of complex movement disorders.

Current Projects

Clinical project: Retrospective review of patients admitted with status dystonicus (severe, persistent dystonia) to BC Children’s Hospital in the last 10 years, leading to a provincial Status dystonicus management guideline development.

Current Projects


Characterization of a new genetic disorder associated with hemiplagic migraines, coma, progressive spasticity, weakness, seizure disorder, spinal cord atrophy, and systemic serotonin deficiency. The research of a family with the above described phenotype lead to discovery of disruption of cytoskeletal and axonal transport, and will cause cytoskeletal aggregates in neurons, that will keep neurotransmitter transporters (serotonin transporter) and other membrane expressed proteins (e.g. Na/K ATPase). This disorder has similarities with ALS, and could be a major breakthrough in ALS research. This research also include calcium imaging in human neuronal iPSC’s.

Grants

Dravet Foundation Canada, Drug response on intraneuronal Ca2+ signaling in neuronal IPScells in Dravet syndrome, $25,000 (Aug 2024- Sep 2025)

RDMM Network, Exploring the mechanism of Ca2+ signaling in neuronal IPScells in Dravet syndrome, $30,000 (Mar 2025- Feb 2026)

Dystonia Medical Research Foundation Canada, Validation of a clinical and deep learning-based tool for recognition, assessment, and monitoring of complex movement disorders, $9,000 (Sep 2024-Aug 2025)

BC Children’s Hospital Foundation, Characterization of CSF metabolome in patients with secondary neurotransmitter deficiencies, $10,000 (Aug 2024- Jul 2025)

Honours & Awards

“Excellence in Research Mentorship”, award from the Neurology residents, awarded at the Annual Neurology Resident Research Day, in 2015, 2016, 2017

Clinical Investigator Program, two year scholarship awarded (July 2008 to June 2010)

Laura MacRae Award 2007 (awarded to outstanding graduate student in the Dept. of Pediatrics, UBC, by the College of Physicians and Surgeons of British Columbia, June 2007

Rookie of the Year 2007, (awarded by the Pediatric Residents, UBC, at the Annual Graduation and Awards Dinner), June 2007.

Related News

Every day, our researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

Our Research

At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.

EXPLORE OUR RESEARCH

Stay in the Know

Sign up for compelling stories about innovative science, the doctors and researchers who turn ideas into discoveries and treatments, and the kids and families whose lives are changed.

This field is for validation purposes and should be left unchanged.